In Vivo Measurements of Nasal Ciliary Beat Frequency by Using Interferometry
NCT ID: NCT02699177
Last Updated: 2016-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2016-04-30
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Assessments of the effect of drugs and other therapies on CBF using the study system.
3. Comparison of results with standard methods such as ciliary brush biopsies
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Acute Cerebral Diseases on the Autonomous Nervous System: Progression and Correlation to Therapy and Outcome
NCT02999659
Reliability of Hertel Exophthalmometer Measurements
NCT01691183
Eye-tracking Based Amblyopia Training
NCT05078099
Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow
NCT02080676
Ocular Microtremor in Parkinson's Disease.
NCT06051877
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The diagnosis of PCD is based on a combination of clinical findings such as bronchiectasis, chronic sinusitis, chronic otitis media and immotile sperms.
In addition, in tests performed in the pulmonary laboratory nasal nitric oxide levels may be low.
Samples obtained by nasal brush biopsy can be analyzed and the ciliary movement recorded by video microscopy. Ciliary beat frequency (CBF) can be calculated in freshly isolated samples but also after growing the tissue in cell culture.
Furthermore, ciliated cells can be analyzed by electron microscopy to detect defects in the microscopic structure of the cilia.
The major problem encountered by all these assays is that they are performed under in vitro conditions and not in the natural environment of the cells where the acidity (pH), temperature, electrolytes etc. may be very different.
Moreover, genetic testing is limited to mutations known to cause PCD, ruling out mutations not yet discovered.
Therefore a method is needed to unequivocally measure ciliary movement in the natural environment.
Goal
1. Assessment of a high speed video camera with a green light source for the measurement of ciliary beat frequency (CBF) in the nasal airways of patients.
2. Assessments of the effect of drugs and other therapies on CBF using the study system.
Methods The protocol has been approved by the local Institutional Review Board (IRB) of the Hadassah Medical Center, Jerusalem, Israel
Equipment:
1. High Speed High Video Microscope built to specifications needed for this study based on a commercially available high speed video system.
2. The green light source (LED) used consists of a spot of 3mm diameter and has an energy of 10 milli Watt ( equal to 1Kilowatt/square meter)
3. Video camera (manufactured by SONY Inc, Japan)
Patients:
Patients referred for ciliary brush biopsy will be asked to sign the informed consent and to be enrolled into the study.
Patients will be examined by having a high speed digital video camera placed close to the nasal cavity in order to photograph the area of interest. The camera lens will be off focus and the reflected light from the nasal mucosa will be recorded. This reflected light recording will be analyzed to obtain the CBF, heart rate and respiratory rate.
After the recording the patient will proceed to the nasal brush ciliary biopsy. The cells will be analyzed by a CBF will be calculated from several areas of the smear.
Safety measures:
All participating patients will wear a protective cover over their eyes during photography.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suspected PCD but negative
CBF measurements:
1. Patients with suspected PCD will have their nasal cavity photographed using a Sony-video camera that will record the reflected light of a green LED bulb.Ciliary beat frequency (CBF) will be calculated by interferometry using a program developed by the PI.
2. Patients will undergo a nasal brush biopsies. The fresh biopsies will be analyzed by high-speed video microscopy to calculate CBF.
3. The two methods will be compared.
CBF measurements
CBF measurements
Suspected PCD but positive
CBF measurements:
1. Patients with suspected PCD will have their nasal cavity photographed using a Sony-video camera that will record the reflected light of a green LED bulb.Ciliary beat frequency (CBF) will be calculated by interferometry using a program developed by the PI.
2. Patients will undergo a nasal brush biopsies. The fresh biopsies will be analyzed by high-speed video microscopy to calculate CBF.
3. The two methods will be compared.
CBF measurements
CBF measurements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBF measurements
CBF measurements
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SHOSEYOV DAVID
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Shoseyov, MD
Role: PRINCIPAL_INVESTIGATOR
Hadassah Medical Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Medical Organization
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0366-15-HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.